He is currently a Venture Partner at ARCH Venture Partners, a Venture Advisor at Atlas Ventures, an Executive Partner at RTW Investments, and Senior Advisor for Blackstone Life Sciences. He is also a member of the Board of Directors of publicly traded companies, including Agios Pharmaceuticals, Beam Therapeutics, Kymera Therapeutics, ProKidney Corp., and Takeda Pharmaceuticals. He is also on the Board of a number of private companies, including Aerium, Hemab, Aera, and Versanis, and on the Board of the Biotechnology Innovation Organization, or “BIO,” where he was Chair from 2017-2019 and is Chair Emeritus. In addition, he serves on the Board of the Termeer Foundation (committed to continuing the legacy of the late Henri A. Termeer) as Chair of the n-Lorem Foundation Advisory Council (committed to meeting the needs of patients with nano-rare diseases), on the Advisory Board of Ariadne Labs (advancing global health system innovations), and as an advisor to Nucleate, a student-led organization facilitating the formation of pioneering life sciences companies. Dr. Maraganore also serves as a strategic advisor to a number of innovative biotechnology companies, with a focus on mentoring CEOs in their mission to advance science and innovation for patients.